Literature DB >> 20210522

Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.

Michael Sand1, Thilo Gambichler, Marina Skrygan, Daniel Sand, Nina Scola, Peter Altmeyer, Falk G Bechara.   

Abstract

BACKGROUND: Dysregulation of microRNA (miRNA) metabolism has been observed in a variety of human cancers. In this pilot study, we investigated expression profiles of the two most important enzymes of the miRNA machinery, Drosha and Dicer, in relation to epithelial skin cancer and its premalignant stage.
METHODS: Patients with premalignant actinic keratoses (AK, n = 6), basal cell carcinomas (BCC, n = 15), and squamous cell carcinomas (SCC, n = 7) were included in the study. Punch biopsies were harvested from the center of the tumors (lesional) as well as from sites of healthy skin (intraindividual controls). Skin samples (n = 14) were also obtained from healthy subjects for additional controls. Dicer and Drosha mRNA levels were detected by quantitative real-time reverse transcriptase polymerase chain reaction.
RESULTS: Drosha expression levels were significantly upregulated in both the BCC and SCC groups compared to those in the healthy controls (p < .01), while Dicer expression levels in the BCC group were significantly lower (p < .05). Dicer expression in the SCC group was significantly higher compared to intraindividual controls (p < .05), while Dicer expression levels in both the SCC and AK groups were not significantly different from healthy control samples (p > .05). In the premalignant AK group, we could not observe any significant difference in Drosha or Dicer expression levels compared to either healthy or intraindividual controls (p > .05).
CONCLUSIONS: We observed dysregulation of Drosha and Dicer expression in epithelial tumors when compared to healthy control samples. Therefore, we favor the hypothesis that miRNAs are involved in the carcinogenesis of epithelial skin cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210522     DOI: 10.3109/07357901003630918

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  41 in total

1.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

Review 2.  Dysregulation of microRNA biogenesis machinery in cancer.

Authors:  Akiko Hata; Risa Kashima
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-12-01       Impact factor: 8.250

Review 3.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

4.  Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.

Authors:  Haifeng Zhao; Le Zhang; Shanqi Guo; Tian Yuan; Bing Xia; FuLian Qu; Lianyu Zhang; Yizhuo Zhang
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

5.  Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.

Authors:  Yuqi Guo; Peng Tian; Chuanhe Yang; Zhibing Liang; Min Li; Michelle Sims; Lu Lu; Zhan Zhang; Hongwei Li; Lawrence M Pfeffer; Junming Yue
Journal:  Pharm Res       Date:  2015-03       Impact factor: 4.200

Review 6.  A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Int Rev Cell Mol Biol       Date:  2017-04-21       Impact factor: 6.813

Review 7.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

8.  Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.

Authors:  Hailong Zhang; Yixuan Hou; Liyun Xu; Zongyue Zeng; Siyang Wen; Yan-E Du; Kexin Sun; Jiali Yin; Lei Lang; Xiaoli Tang; Manran Liu
Journal:  Dig Dis Sci       Date:  2015-12-22       Impact factor: 3.199

Review 9.  DICER1: mutations, microRNAs and mechanisms.

Authors:  William D Foulkes; John R Priest; Thomas F Duchaine
Journal:  Nat Rev Cancer       Date:  2014-09-01       Impact factor: 60.716

Review 10.  Control by a hair's breadth: the role of microRNAs in the skin.

Authors:  Matthew S Ning; Thomas Andl
Journal:  Cell Mol Life Sci       Date:  2012-09-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.